A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: intolerable (21), improper (9), offensive (26), undesirable (4), objectionable (1)

Same-sex-accommodation-policy

Description
Same Sex Accommodation Policy Date Issued: 13 March 2018 Review Date: 24 January 2021 Document Type: Policy Version: 2.1 Contents 1 2 3 4 5 6 7 8 9 10 11 Exe
Url
/Media/UHS-website-2019/Docs/For-patients/same-sex-accommodation-policy.pdf

Eye expert warns 'misconception' among surgeons causing sight loss

Description
A leading eye expert has warned some patients in the UK may be losing their sight unnecessarily due to a "poor
Url
/AboutTheTrust/Newsandpublications/Latestnews/2017/December-2017/Eye-expert-warns-misconception-among-surgeons-causing-sight-loss.aspx

Rucaparib

Description
A document based on Rucarib, an ovarian cancer condition.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Rucaparib.pdf

Apalutamide v1

Description
Chemotherapy Protocol PROSTATE APALUTAMIDE Regimen  Prostate cancer Indication  Apalutamide is recommended for non-metastatic prostate cancer as defined
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Apalutamide-v1.pdf

Tivozanib

Description
Chemotherapy Protocol RENAL CELL Regimen TIVOZANIB • Renal Cell - Tivozanib Indication • Patients with a confirmed histological diagnosi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Tivozanib.pdf

Olaparib Tablets

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCERS OLAPARIB (tablets) This regimen may require funding. Regimen • Ovarian Cancer – Olaparib (tablets) Indication • Olapari
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Olaparib-Tablets.pdf

Handling concerns and complaints policy

Description
Handling Complaints Policy, Version 13.0 Trust reference PET003 Version number 13.0 Description Policy to explain how University Hospital Southam
Url
/Media/UHS-website-2019/Docs/Policies/Handling-concerns-and-complaints-policy.pdf

Capecitabine-TrastuzumabIV-Tucatinib

Description
Chemotherapy Protocol BREAST CANCER Capecitabine–Trastuzumab (IV)-Tucatinib Regimen • Breast Cancer – Capecitabine–Trastuzumab (IV)-
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine-Trastuzumab-IV-Tucatinib.pdf

Capecitabine-Trastuzumab-SC-Tucatinib

Description
Chemotherapy Protocol BREAST CANCER Capecitabine– Trastuzumab (SC)-Tucatinib Regimen • Breast Cancer – Capecitabine–Trastuzumab (SC)
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine-Trastuzumab-SC-Tucatinib.pdf

Avelumab(800mg)

Description
Chemotherapy Protocol BLADDER CANCER AVELUMAB (800mg) Regimen  Bladder Cancer - Avelumab Indication  Avelumab is indicated as monotherapy for the first-line maintenance
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Avelumab800mg.pdf
1 to 10 of 93
Previous 1 2 3 4 5 … Next